1. X
  2. Ansa Biotechnologies
Log inSign up
Ansa Biotechnologies
381 posts
Ansa Biotechnologies profile banner
user avatar

Ansa Biotechnologies

@AnsaBio
Enabling the next generation of DNA synthesis using enzymes. You can also find us at @ansabio.bsky.social
San Francisco, CA
ansabio.com
Joined May 2018
281
Following
1,356
Followers
RepliesRepliesMediaMedia

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
  • user avatar
    Ansa Biotechnologies
    @AnsaBio
    Aug 20
    In June, 96% of Ansa orders shipped on time or early. 𝗧𝗵𝗲 𝗼𝘁𝗵𝗲𝗿 𝟰% 𝗦𝗵𝗶𝗽𝗽𝗲𝗱 𝗳𝗿𝗲𝗲. That's the Ansa On-Time Guarantee: miss the date, you don't pay. 𝟵𝟵.𝟴% 𝗼𝗳 𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗲𝘀 𝘄𝗲𝗿𝗲 𝗳𝘂𝗹𝗳𝗶𝗹𝗹𝗲𝗱. See how it works: hubs.li/Q04tJT5z0
    Image
    Image
    Image
    Image
  • user avatar
    Ansa Biotechnologies
    @AnsaBio
    Aug 14
    💡 Fun Fact Friday: We went from 600 bp → 50 kb in just 15 months. The bigger story? Expanding what researchers can design, build, and explore. More design freedom. More possibilities. More room to push science forward. What will you build with 50 kb? hubs.li/Q04t4hp20
    Image
  • user avatar
    Ansa Biotechnologies
    @AnsaBio
    Aug 13
    Today’s AI models can predict expression, optimize sequences, design CRISPR guides, and generate entirely new proteins and DNA sequences. The challenge is turning those digital designs into physical constructs that can actually be tested. Let's dive in!
    Image
    How AI Is Changing DNA and Gene Design | Ansa Biotechnologies
    From ansabio.com
  • user avatar
    Ansa Biotechnologies
    @AnsaBio
    Aug 6
    🧬 AI can now design mRNA sequences no one would've thought to try. The catch? Some of them are nearly impossible to actually build. Our CSO & Co-founder, @dan161803 spoke with @biocompare about this gap between AI-designed and AI-buildable. 👉
    Image
    biocompare.com
    Next-Generation Vaccines Build On mRNA’s Breakthrough
    New tools are extending the gains mRNA vaccines made during COVID-19
  • user avatar
    Ansa Biotechnologies
    @AnsaBio
    Jul 30
    Synthetic DNA companies don't usually ask to be regulated. We're doing it anyway. In a new op-ed for @TheScientistLLC , our CEO @Jason_Gammack argues that the current biosecurity screening honor system isn't enough. Read the full piece here: hubs.li/Q04r1-9G0
    Image
Advertisement
Advertisement